Tactile Systems Technology Inc (TCMD) — SEC Filings
Tactile Systems Technology Inc (TCMD) — 26 SEC filings. Latest: ARS (Mar 25, 2026). Includes 6 10-Q, 5 8-K, 5 SC 13G/A.
View Tactile Systems Technology Inc on SEC EDGAR
Overview
Tactile Systems Technology Inc (TCMD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Mar 25, 2026: Tactile Systems Technology Inc. filed its Annual Report to Security Holders (ARS) on March 25, 2026, for the fiscal year ending December 31, 2025. This filing, with SEC Accession No. 0001104659-26-034210, provides shareholders with a comprehensive overview of the company's financial performance and
Sentiment Summary
Across 26 filings, the sentiment breakdown is: 2 bearish, 23 neutral, 1 mixed. The dominant filing sentiment for Tactile Systems Technology Inc is neutral.
Filing Type Overview
Tactile Systems Technology Inc (TCMD) has filed 1 ARS, 1 DEFA14A, 6 10-Q, 5 8-K, 2 DEF 14A, 2 10-K, 4 SC 13G, 5 SC 13G/A with the SEC between Jan 2024 to Mar 2026.
Filings by Year
Recent SEC Filings (26)
Risk Profile
Risk Assessment: Of TCMD's 16 recent filings, 0 were flagged as high-risk, 8 as medium-risk, and 8 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $85.755M |
| Net Income | $8.209M |
| Cash Position | $65.965M |
| Total Assets | $259.177M |
| Total Debt | $0 |
Key Executives
- Todd M. Thompson
- Robert J. K. Johnson
- David R. Johnson
- Sheri L. Dodd
- Reuvers
- Robert L. Smith
- James E. Culbert
- Robert J. Weninger
Industry Context
Tactile Systems Technology operates in the medical device industry, specifically focusing on neurostimulation devices for conditions like lymphedema and chronic pain. The industry is characterized by significant R&D investment, stringent regulatory oversight (FDA), and reliance on reimbursement from third-party payers. Key trends include technological advancements, increasing adoption of home-based therapies, and a growing aging population driving demand for chronic condition management solutions.
Top Tags
corporate-governance (4) · 10-Q (4) · Medical Devices (3) · financials (3) · annual-report (2) · regulatory-filing (2) · board-of-directors (2) · executive-compensation (2) · 10-K (2) · cfo (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Total Revenue (Q3 2025) | $85.755M | Increased 17.3% from $73.093M in Q3 2024 |
| Net Income (Q3 2025) | $8.209M | Increased 59.2% from $5.155M in Q3 2024 |
| Total Revenue (YTD 2025) | $225.928M | Increased 8.0% from $207.399M in YTD 2024 |
| Net Income (YTD 2025) | $8.452M | Increased 16.7% from $7.244M in YTD 2024 |
| Cash (Sept 30, 2025) | $65.965M | Decreased from $94.367M at Dec 31, 2024 |
| Common Stock Repurchases (YTD 2025) | $26.562M | Significant cash outflow for share buybacks |
| Note Payable Payments (YTD 2025) | $26.250M | Significant cash outflow for debt reduction |
| Shares Outstanding (Oct 30, 2025) | 22,335,582 | Reduced from 23,883,475 at Dec 31, 2024 due to repurchases |
| Q2 2025 Revenue | $68.5M | Increased 10.3% from $62.1M in Q2 2024 |
| Q2 2025 Net Income | -$2.3M | Shifted from a $1.5M net income in Q2 2024 to a net loss |
| Q2 Revenue Growth | 10.3% | Year-over-year increase for the three months ended June 30, 2025 |
| Six-Month Net Income | -$5.8M | Net loss for the six months ended June 30, 2025, compared to $0.8M net income in 2024 |
| Shares Authorized | 1,500,000 | For the 2025 Equity Incentive Plan adopted on May 7, 2025 |
| Q2 2025 Share-Based Compensation | $5.1M | Increased from $4.2M in Q2 2024, contributing to net loss |
| New Directors | 2 | Robert J. K. Johnson and David R. Johnson were elected to the Board. |
Forward-Looking Statements
- {"claim":"Vanguard's slight reduction in TCMD shares will not significantly impact the stock price in the short term.","entity":"TCMD","targetDate":"3 months","confidence":"medium"}
Frequently Asked Questions
What are the latest SEC filings for Tactile Systems Technology Inc (TCMD)?
Tactile Systems Technology Inc has 26 recent SEC filings from Jan 2024 to Mar 2026, including 6 10-Q, 5 8-K, 5 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of TCMD filings?
Across 26 filings, the sentiment breakdown is: 2 bearish, 23 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Tactile Systems Technology Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Tactile Systems Technology Inc (TCMD) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Tactile Systems Technology Inc?
Key financial highlights from Tactile Systems Technology Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for TCMD?
The investment thesis for TCMD includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Tactile Systems Technology Inc?
Key executives identified across Tactile Systems Technology Inc's filings include Todd M. Thompson, Robert J. K. Johnson, David R. Johnson, Sheri L. Dodd, Reuvers and 3 others.
What are the main risk factors for Tactile Systems Technology Inc stock?
Of TCMD's 16 assessed filings, 0 were flagged high-risk, 8 medium-risk, and 8 low-risk.
What are recent predictions and forward guidance from Tactile Systems Technology Inc?
Recent forward-looking statements from Tactile Systems Technology Inc include guidance on {"claim":"Vanguard's slight reduction in TCMD shares will not significantly impact the stock price in the short term.",".